Nothing Special   »   [go: up one dir, main page]

Marcilla et al., 2014 - Google Patents

Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residue

Marcilla et al., 2014

View HTML @Full View
Document ID
7925600028001457570
Author
Marcilla M
Alpízar A
Lombardía M
Ramos-Fernandez A
Ramos M
Albar J
Publication year
Publication venue
Molecular & Cellular Proteomics

External Links

Snippet

Human leukocyte antigen (HLA) class I molecules bind peptides derived from the intracellular degradation of endogenous proteins and present them to cytotoxic T lymphocytes, allowing the immune system to detect transformed or virally infected cells. It is …
Continue reading at www.mcponline.org (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70539MHC-molecules, e.g. HLA-molecules
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids

Similar Documents

Publication Publication Date Title
Marcilla et al. Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residue
Purcell et al. Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
Chong et al. High-throughput and sensitive immunopeptidomics platform reveals profound interferonγ-mediated remodeling of the human leukocyte antigen (HLA) ligandome
Hassan et al. The human leukocyte antigen–presented ligandome of B lymphocytes
Barber et al. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes
Lee et al. Architecture mapping of the inner mitochondrial membrane proteome by chemical tools in live cells
Purcell et al. Immunoproteomics: mass spectrometry-based methods to study the targets of the immune response
Alpízar et al. A molecular basis for the presentation of phosphorylated peptides by HLA-B antigens
Zarling et al. Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo
Pierce et al. Cutting edge: the HLA-A* 0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique
Sofron et al. High‐resolution analysis of the murine MHC class II immunopeptidome
Ritz et al. High‐sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients’ sera
Udaka et al. An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries
Chen et al. Identification of MHC peptides using mass spectrometry for neoantigen discovery and cancer vaccine development
Schumacher et al. Building proteomic tool boxes to monitor MHC class I and class II peptides
Mester et al. Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands
Petrotchenko et al. Use of proteinase K nonspecific digestion for selective and comprehensive identification of interpeptide cross-links: application to prion proteins
Jarmalavicius et al. High immunogenicity of the human leukocyte antigen peptidomes of melanoma tumor cells
Pritchard et al. Exploration of peptides bound to MHC class I molecules in melanoma
Giam et al. A comprehensive analysis of peptides presented by HLA‐A1
Gebreselassie et al. Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B* 5101 with peptides
EP1105731B1 (en) Profiling and cataloging expressed protein tags
Espinosa et al. Peptides presented by HLA class I molecules in the human thymus
Mangalaparthi et al. Digging deeper into the immunopeptidome: characterization of post-translationally modified peptides presented by MHC I
Antwi et al. Proteomic identification of an MHC-binding peptidome from pancreas and breast cancer cell lines